IFU (PDF) | Contrast Agent | Ionic/Nonionic | Osmotic Concentration | Manufacturer | Carotid | LCA | RCA | LV | Aorta | Celiac | Renal | Mesenteric | Iliac | Femoral | Viscosity (cPs) | Half Life | Remarks |
Cholografin
| lodipamide | Ionic | low osmolar | Bracco Diagnostics | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | | | * visualization of the gallbladder and biliary ducts in the differential diagnosis of acute abdominal conditions
* visualization of the biliary ducts, especially in patients with symptoms after cholecystectomy
* visualization of the gallbladder in patients unable to take oral contrast media or to absorb contrast media from the gastrointestinal tract. |
Conray 30
| Iothalamate | Ionic | low osmolar | Mallinckrodt | 3-10 ml | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | 15-30 ml | | | | | | 1.5 | 90 min. | * Intravenous infusion urography, contrast enhancement of computed tomographic brain images and arterial digital subtraction angiography. |
Conray 43
| Iothalamate | Ionic | low osmolar | Mallinckrodt | 3-10 ml | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | 15-30 ml | | | | | | 2.0 | 90 min. | * lower extremity venography, intravenous infusion urography, contrast enhancement of computed tomographic brain images and arterial digital subtraction angiography. |
Conray
| Iothalamate | Ionic | low osmolar | Mallinckrodt | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 4.0 | 90 min. | * excretory urography, cerebral angiography, peripheral
arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, in travenous digital subtraction angiography and arterial digital subtraction angiography. |
Eovist
| Gadoxetate | | low osmolar | Bayer HealthCare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 1.19 | 0.95 hr. | |
Hexabrix
| Ioxaglate | Ionic | low osmolar | Guerbet | 6-10 ml | 8 ml | 5 ml | 45 ml | 25-50 ml | 40 ml | | 20-40 ml | 40 ml | 30 ml | 7.5 | 92 min. | |
Isovue 200
| Iopamidol | Non Ionic | low osmolar | Bracco Diagnostics | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 2.0 | 2 hrs. | Peripheral Venography (not to exceeded 350 mL) |
Isovue 250
| Iopamidol | Non Ionic | low osmolar | Bracco Diagnostics | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 3.0 | 2 hrs. | Excretory Urography |
Isovue 300
| Iopamidol | Non Ionic | low osmolar | Bracco Diagnostics | 8-12 ml | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | 25-50 ml | | | | 25-50 ml | 5-40 ml | 4.7 | 2 hrs. | Cerebral Arteriography
Excretory Urography |
Isovue 370
| Iopamidol | Non Ionic | low osmolar | Bracco Diagnostics | 8-12 ml | 2-10 ml | 2-10 ml | 25-50 ml | 25-50 ml | 50 ml | 10 ml | | 25-50 ml | 5-40 ml | 9.4 | 2 hrs. | The elimination serum or plasma half-life is approximately two hours; the half-life is not dose dependent. No significant metabolism, deiodination, or biotransformation occurs. |
Lipiodol
| Ethiodol | | | Guerbet | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | | | *In diagnostic radiology
Lymphography: intralymphatic injection only
Diagnosis of liver lesions: selective intra-arterial injection only
*In interventional radiology
Embolization with surgical glues: selective intra-arterial injection only
*In iodine deficiency
Intramuscular injection only |
Magnevist
| Gadopentetate | Ionic | | Bayer HealthCare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 2.9 | 1.6 hrs | For use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues, in the head and neck, and in the body (excluding the heart).
Upon injection, the meglumine salt is completely dissociated from the gadopentetate dimeglumine complex. Gadopentetate is exclusively eliminated in the urine with 83 ± 14% (mean ± SD) of the dose excreted within 6 hours and 91 ± 13% (mean ± SD) by 24 hours, post-injection. |
MD 76
| Diatrizoate | Ionic | high osmolar | Mallinckrodt | | 4-10 ml | 4-10 ml | 35-50 ml | | | 5-10 ml | | | 20-40 ml | 10.5 | 100 min. | * excretion urography, aortography, pediatric angiocardiography, peripheral arteriography, selective renal arteriography, selective visceral arteriography, selective coronary arteriography with or without left ventriculography, contrast enhancement of computed tomographic brain imaging and for intravenous digital subtraction angiography. |
MultiHance
| Gadobenate | Ionic | | Bracco Diagnostics | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 5.3 | | For intravenous use in magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults and children over 2 years of age to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues and use in magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease. |
Omnipaque 140
| Iohexol | Non Ionic | low osmolar | GE Healthcare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 1.5 | | Cerebral, neck, abdominal, renal and peripheral vessels |
Omnipaque 180
| Iohexol | Non Ionic | low osmolar | GE Healthcare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 2.0 | | Intrathecal administration |
Omnipaque 240
| Iohexol | Non Ionic | low osmolar | GE Healthcare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | 2.4 | | Intrathecal administration
Cerebral, neck, abdominal, renal and peripheral vessels
*Venography (per leg):
20 mL to 150 mL of OMNIPAQUE 240 (240 mgI/mL) |
Omnipaque 300
| Iohexol | Non Ionic | low osmolar | GE Healthcare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | 50-80 ml | 30-60 ml | 5-15 ml | 30-60 ml | 8-25 ml | 9-20 ml | 6.3 | | Intrathecal administration
*Aortofemoral runoffs:
30 mL to 90 mL of OMNIPAQUE 300 (300 mgI/mL)
*Selective arteriograms (femoral/iliac):
10 mL to 60 mL of OMNIPAQUE 300 (300 mgI/mL)
*Venography (per leg):
40 mL to 100 mL of OMNIPAQUE 300 (300 mgI/mL) |
Omnipaque 350
| Iohexol | Non Ionic | low osmolar | GE Healthcare | 6-12 ml | 5 ml | 5 ml | 40 ml | 50-80 ml | 30-60 ml | 5-15 ml | 30-60 ml | 8-25 ml | 9-20 ml | 10.4 | | *Aortofemoral runoffs:
20 mL to 70 mL of OMNIPAQUE 350 (350 mgI/mL)
*Selective arteriograms (femoral/iliac):
10 mL to 30 mL of OMNIPAQUE 350 (350 mgI/mL) |
Omniscan
| Gadodiamide | Non Ionic | | GE Healthcare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | | | Gadolinium-based contrast agent for diagnostic magnetic resonance imaging (MRI) indicated for intravenous use to:
• Visualize lesions with abnormal vascularity in the brain, spine, and associated tissues
• Facilitate the visualization of lesions with abnormal vascularity within the thoracic, abdominal, pelvic cavities, and the retroperitoneal spac |
Optimark
| Gadoversetamide | Non Ionic | | Mallinckrodt | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | | | | For use with magnetic resonance imaging (MRI) in patients with abnormal blood brain barrier or abnormal vascularity of the brain, spine and associated tissues, and abnormal vascularity in the liver in patients who are highly suspect for liver structural abnormalities on computed tomography. |
Optiray 240
| Ioversol | Non Ionic | low osmolar | Mallinckrodt | | | | | | | | | | | 3.0 | | * Optiray 240: 3.0 cPs (Cerebral Angiography and Venography) |
Optiray 300
| Ioversol | Non Ionic | low osmolar | Mallinckrodt | | | | | | | | | | | 5.5 | | * Optiray 300: 5.5 cPs (Cerebral and Peripheral Angiography) |
Optiray 320
| Ioversol | Non Ionic | low osmolar | Mallinckrodt | | 8 ml | 6 ml | 40 ml | 45 ml | 45 ml | 9 ml | 4 ml | 60 ml | 40 ml | 5.8 | | Optiray 320: 5.8 cPs (Cardiac Angiography) |
Optiray 350
| Ioversol | Non Ionic | low osmolar | Mallinckrodt | | 8 ml | 6 ml | 40 ml | 45 ml | 45 ml | 9 ml | 45 ml | 60 ml | 40 ml | 9.0 | | * Optiray 350: 9.0 cPs (Cardiac Angiography) |
Oxilan 300
| Ioxilan | Non Ionic | low osmolar | Guerbet | 8-12 ml | | | | | | | | | | 5.1 | | * Cerebral Arteriography |
Oxilan 350
| Ioxilan | Non Ionic | low osmolar | Guerbet | | 2-10 ml | 2-10 ml | 25-50 ml | 45-100 ml | | | | | 10-40 ml | 8.1 | | * Coronary Arteriography and Left Ventriculography, Visceral Angiography, Aortography, and Peripheral Arteriography |
Ultravist 150
| Iopromide | Non Ionic | low osmolar | Bayer HealthCare | 6-10 ml | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | 20-50 ml | 2-20 ml | | | | | 1.5 | | * Intra-Arterial Digital Subtraction Angiography (IA-DSA) |
Ultravist 240
| Iopromide | Non Ionic | low osmolar | Bayer HealthCare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | 5-40 ml | 2.8 | | * Ultravist 240 mg I/mL: 2.8 cPs (Peripheral Venography) |
Ultravist 300
| Iopromide | Non Ionic | low osmolar | Bayer HealthCare | 3-12 ml | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | | | | | | 5-40 ml | 4.9 | | * Cerebral Arteriography and Peripheral Arteriography
* Excretory Urography |
Ultravist 370
| Iopromide | Non Ionic | low osmolar | Bayer HealthCare | | 3-14 ml | 3-14 ml | 30-60 ml | 20-50 ml | | | | | | 10 | 2.3 hrs | * Coronary Arteriography and Left Ventriculography, Visceral Angiography, and Aortography
* Ultravist 370 mg l/mL: 10.0 cPs (Cardiac Angiography) |
Vispaque 270
| Iodixanol | Non Ionic | low osmolar | GE Healthcare | | Not 4 ♥. | Not 4 ♥. | Not 4 ♥. | 20-50 ml | 5-30 ml | 10-25 ml | 5-30 ml | | | 6.3 | | Vispaque 270: 6.3 cPs Intra-Arterial Digital Subtraction Angiography (IA-DSA) |
Vispaque 320
| Iodixanol | Non Ionic | low osmolar | GE Healthcare | 10-14 ml | 3-10 ml | 3-8 ml | 20-45 ml | 30-70 ml | | 8-18 ml | 10-70 ml | | 20-90 ml | 11.8 | 2.1 hrs | Vispaque 320: 11.8 cPs (Cerebral, Peripheral, Cardiac, Visceral) |